Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Di Blasi R, Le Gouill S, Bachy E, Cartron G, Beauvais D, Le Bras F, Gros FX, Choquet S, Bories P, Feugier P, Casasnovas O, Bay JO, Mohty M, Joris M, Gastinne T, Sesques P, Tudesq JJ, Vercellino L, Morschhauser F, Gat E, Broussais F, Houot R, Thieblemont C. Di Blasi R, et al. Among authors: tudesq jj. Blood. 2022 Dec 15;140(24):2584-2593. doi: 10.1182/blood.2022016945. Blood. 2022. PMID: 36122385 Free article.
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.
Vallet N, Chevret S, Feghoul L, Aguinaga L, Bondeelle L, Kaphan E, Bertinchamp R, Soret J, Villesuzanne C, De Castro N, Sebert M, Boutboul D, Lengline E, Tudesq JJ, Rabian F, Adès L, Xhaard A, Di Blasi R, Raffoux E, Galicier L, Le Goff J, Delaugerre C, Bergeron A, Harel S; Saint-Louis CORE group. Vallet N, et al. Among authors: tudesq jj. Blood Cancer J. 2021 Jul 14;11(7):129. doi: 10.1038/s41408-021-00512-5. Blood Cancer J. 2021. PMID: 34262018 Free PMC article. No abstract available.
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy.
Lamure S, Van Laethem F, De Verbizier D, Lozano C, Gehlkopf E, Tudesq JJ, Serrand C, Benzaoui M, Kanouni T, Quintard A, De Vos J, Tchernonog E, Platon L, Ayrignac X, Ceballos P, Sirvent A, François M, Guedon H, Quittet P, Mongellaz C, Conte A, Herbaux C, Bret C, Taylor N, Dardalhon V, Cartron G. Lamure S, et al. Among authors: tudesq jj. Cancers (Basel). 2021 Aug 25;13(17):4279. doi: 10.3390/cancers13174279. Cancers (Basel). 2021. PMID: 34503088 Free PMC article.
[Complications other than infections, CRS and ICANS following CAR T-cells therapy: Recommendations of the Francophone Society of bone marrow transplantation and cell therapy (SFGM-TC)].
Pochon C, Courbon C, Bay JO, Moreau AS, Paul F, Picard M, Sterin A, Tudesq JJ, Vicente C, Yakoub-Agha M, Yakoub-Agha I. Pochon C, et al. Among authors: tudesq jj. Bull Cancer. 2021 Dec;108(12S):S98-S103. doi: 10.1016/j.bulcan.2021.10.004. Epub 2021 Nov 19. Bull Cancer. 2021. PMID: 34802718 French.
[Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Paul F, Vicente C, Courbon C, Moreau AS, Picard M, Pochon C, Sterin A, Tudesq JJ, Yakoub-Agha M, Bay JO, Yakoub-Agha I. Paul F, et al. Among authors: tudesq jj. Bull Cancer. 2021 Dec;108(12S):S90-S97. doi: 10.1016/j.bulcan.2021.11.001. Epub 2021 Dec 6. Bull Cancer. 2021. PMID: 34876272 Review. French.
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.
Bachy E, Le Gouill S, Di Blasi R, Sesques P, Manson G, Cartron G, Beauvais D, Roulin L, Gros FX, Rubio MT, Bories P, Bay JO, Llorente CC, Choquet S, Casasnovas RO, Mohty M, Guidez S, Joris M, Loschi M, Carras S, Abraham J, Chauchet A, Drieu La Rochelle L, Deau-Fischer B, Hermine O, Gastinne T, Tudesq JJ, Gat E, Broussais F, Thieblemont C, Houot R, Morschhauser F. Bachy E, et al. Among authors: tudesq jj. Nat Med. 2022 Oct;28(10):2145-2154. doi: 10.1038/s41591-022-01969-y. Epub 2022 Sep 22. Nat Med. 2022. PMID: 36138152 Free PMC article.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Le Calvez B, Tessoullin B, Renaud L, Botella-Garcia C, Srour M, Le Gouill S, Guillerm G, Gressin R, Nguyen Quoc S, Furst S, Chauchet A, Sibon D, Lewalle P, Poiré X, Maillard N, Villate A, Loschi M, Paillassa J, Beguin Y, Dulery R, Tudesq JJ, Fayard A, Béné MC, Camus V, Chevallier P, Le Bourgeois A. Le Calvez B, et al. Among authors: tudesq jj. Acta Oncol. 2022 Nov;61(11):1332-1338. doi: 10.1080/0284186X.2022.2130709. Epub 2022 Oct 10. Acta Oncol. 2022. PMID: 36214787 Free article.
31 results